April 8, 2020 FDA approves encorafenib in combination with cetuximab for metastatic colorectal cancer with a BRAF V600E mutation — January 26, 2012 Prahallad A*, Sun C*, Huang S*, Di Nicolantonio F*, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A, Bernards R. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. 2012 […]
“Shared genetic marker offers new promise in targeting specific ovarian and lung cancers” Faculty of Medicine News Med e-News
We have started this section to share our latest accomplishments and let visitors know what are we up to.